- -11%
- New
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
T4 is Dragon Pharma's formulation of Levothyroxine Sodium β synthetic thyroxine β at 50mcg per tablet. T4 is the thyroid gland's primary secretory hormone and a prohormone that must be converted to the active T3 (triiodothyronine) by peripheral deiodinase enzymes before producing its full metabolic effect. With a ~6-7 day half-life, T4 provides the most stable and gradual thyroid support of any thyroid compound in the Dragon Pharma range β a fundamentally different profile from the faster-acting, more potent T3 (Liothyronine).
Also searched as: T4 Levothyroxine 50mcg, L-thyroxine, Synthroid, Levothyroxine Dragon Pharma, T4 thyroid support.
Understanding T4's relationship to T3 is essential to understanding why they are used differently:
Despite T3 being more potent and predictable, T4 has specific applications in the Dragon Pharma context that are rarely explained in competitor content:
| Parameter | T4 (Levothyroxine) | T3 (Liothyronine) |
|---|---|---|
| Form | Prohormone β converted to T3 | Active hormone β direct receptor activation |
| Half-life | ~6β7 days | ~2.5 days |
| Onset of effect | Slow β weeks to stabilise | Fast β days to effective levels |
| Potency per mcg | Lower β requires conversion | Higher β direct activity |
| Effect predictability | Variable β depends on individual conversion | Consistent β direct receptor binding |
| Muscle catabolism risk | Lower β gentler metabolic acceleration | Higher β more aggressive catabolism at equivalent doses |
| Dose titration speed | Slow β 6-7 day half-life means weeks to reach new steady-state | Fast β adjustments show effect within days |
| Taper requirement | Gradual taper advised | Gradual taper essential |
| Primary performance use | Thyroid support, post-T3 axis restoration, mild metabolic lift | Aggressive fat loss, BMR elevation |
| Use Case | Dose | Timing | Duration |
|---|---|---|---|
| Performance thyroid support | 50β100 mcg/day | Morning, fasted | Duration of cycle |
| Post-T3 axis restoration | 50β100 mcg/day | Morning, fasted | 2β4 weeks tapering as natural axis recovers |
| Hypothyroid support during AAS | 50 mcg/day | Morning, fasted | Duration of AAS cycle |
Morning fasted administration is standard for T4 β food, calcium and iron supplements significantly reduce T4 absorption by binding it in the gut. Unlike T3 where splitting doses is sometimes used, T4's 6-7 day half-life makes once-daily morning dosing entirely appropriate for stable blood levels. Due to the long half-life, dose changes take 4-6 weeks to reach new steady-state β dose adjustments must be made conservatively and patiently.